Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Corona Remedies CFO shares growth guidance
Ahmedabad-based pharmaceutical company Corona Remedies remains confident of delivering steady growth over the next few years, backed by its core brands, acquired portfolios and selective acquisitions.
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
Stocks to Watch Today: Rail Vikas Nigam, HFCL, Bosch Home Comfort, Lupin, Corona Remedies, Susan... - Moneycontrol.com
Stocks to Watch Today: Rail Vikas Nigam, HFCL, Bosch Home Comfort, Lupin, Corona Remedies, Susan...Moneycontrol.com
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
'Decade Of Crises': PM Modi Flags Corona, War & Energy Crisis; Cautions Of Poverty If Situation Doesn't Improve
PM Modi also personally appealed to overseas Indians to invest back home, calling it "Modi's guarantee."
Corona Remedies shares fall 3% despite 44% jump in Q4 profit; margins contract
Corona Remedies shares fell over 3% despite strong Q4FY26 and FY26 revenue and profit growth, margin pressure, acquisitions, capacity expansion and EAEU-GMP certification.
Stock Alert: JSW Energy, Heritage Foods, Satin Creditcare, Corona Remedies, Indian Hotels - Business Standard
Stock Alert: JSW Energy, Heritage Foods, Satin Creditcare, Corona Remedies, Indian HotelsBusiness Standard
Corona Remedies consolidated net profit rises 43.68% in the March 2026 quarter
Sales rise 20.23% to Rs 353.09 crore
Corona Remedies jumps after these revelations from the CFO
In an exclusive interview with CNBC-TV18, the CFO of Corona Remedies made at least three comments that helped the stock price jump nearly 2.5% from the day's low.
Aberdeen, ADIA, Ashoka WhiteOak among 9 investors buy 7.34% stake in Corona Remedies from ChrysCapital, Anchor Partners
As of March 2026, Sepia Investments was having a 19.76 percent stake (1.2 crore shares) in Corona Remedies.
The ‘tail brand’ playbook: How Corona Remedies is scripting one of India’s fastest growth stories
The playbook of buying “tail brands” and unlocking latent value has quietly turned Corona into one of India’s fastest-growing players in the branded formulations market.